• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Coronary artery disease - drug-eluting stents (part review of TA71)

Drug-eluting stents for the treatment of coronary artery disease (part review of TA71)

Status:	History
Expected date of issue:	July 2008
Wave:	R
Process:	MTA
Topic area: Cardiovascular Surgical procedures

Project team | Schedule | Stakeholders | Project history | Key documents

 

NICE project team

Executive Lead:	Andrew Dillon
Technical Lead:	Joanna Richardson
Communications manager:	Phil Ranson
Project manager:	Shaun Minehan
Assessment group:	Liverpool Reviews and Implementation Group, University of Liverpool

Top

 

Provisional schedule

Consultation on draft scope by stakeholders:	January 2005
Information meeting with consultees:	31 March 2005
Closing date for invited submissions / evidence submission:	05 July 2005
Final scope published:	February 2004
1st appraisal committee meeting:	01 February 2006
2nd appraisal committee meeting:	03 October 2006
3rd appraisal committee meeting:	04 July 2007
4th appraisal committee meeting:	06 November 2007

Top

 

Consultees and commentators

Consultees Commentators (no right of appeal) Manufacturers / Sponsors Abbott Vascular Devices Ltd Biotronik UK Ltd Boston Scientific Cordis Corporation Guidant Kiwimed Ltd Medtronic AVE Sorin Biomedica UK Ltd Patient / Carer Groups Action Heart British Cardiac Patients Association Coronary Prevention Group HEART UK National Heart Forum Heart Care Partnership (UK) Professional Groups British Association for Nursing in Cardiac Care British Cardiac Society British Cardiovascular Intervention Society British Heart Foundation Royal College of Nursing Royal College of Physicians Pharmaceutical Society of Great Britain Society for Cardiological Science and Technology Society of Cardiothoracic Surgeons of Great Britain and Ireland Others Barnet PCT Central Derby PCT Department of Health Welsh Assembly Government General Association of British Health-Care Industries (ABHI) British Cardiovascular Industry Association (BCIA) Board of Community Health Councils in Wales British National Formulary EUCOMED Medicines and Healthcare products Regulatory Agency (MHRA) National Collaborating Centre for Acute Care National Collaborating Centre for Chronic Conditions National Public Health Service for Wales NHS Confederation NHS Purchasing and Supplies Agency NHS Quality Improvement Scotland Comparator Manufacturers None Assessment Team None Associated Guideline Groups None Associated Public Health Groups None Research Groups None

Top

 

Project history

Date Update 5 September 2007 Project Manager Updated 11 January 2005 Topic summary created on website. 17 January 2005 Draft scope and provisional matrix of consultees and commentators added. 17 January 2005 Technology Appraisal Project Manager changed. 21 February 2005 Final scope, final matrix, summary of comments on the draft scope and summary of comments on the draft matrix added. 6 May 2005 Final protocol added. 20 June 2005 Schedule amended. 11 August 2005 Project manager updated. 10 November 2006 Project manager changed, changes to schedule of appraisal committee meetings and expected date of issue 10 January 2007 Stakeholder list updated. 12 February 2007 NICE is currently conducting a part review of TA71. This review will take account of the recent developments in the evidence base surrounding the use of drug-eluting stents. The Institute is aware of the current uncertainties regarding the use of drug-eluting stents. Health professionals are alerted to the recent regulatory information on drug-eluting stents from the FDA and MHRA websites to inform their decisions regarding the use of drug-eluting stents. 06 September 2007 Date of 4th committee meeting rescheduled to accommodate consultee and commentator consultation on economic models.

Top

 

Key documents

Coronary artery disease - drug-eluting stents (part review of TA71): appeal 29 February 2008 Ischaemic heart disease - coronary artery stents (review): Final Appraisal Determination (FAD) 01 February 2008 Ischaemic heart disease - coronary artery stents (review): appraisal consultation 07 August 2007 Ischaemic heart disease - coronary artery stents (review):Clarification of Addendum 6 08 August 2007 Project specification form 24 February 2006 Final protocol 06 May 2005 Final scope - Ischaemic heart disease - coronary artery stents (review) 11 January 2005 Summary of consultee and commentator comments on the draft scope 11 January 2005 Summary of consultee and commentator comments on the draft matrix 11 January 2005 Archive: Provisional matrix of consultees and commentators 17 January 2005 Archive: Draft scope 17 January 2005

This page was last updated: 30 March 2010